Changing Trends in Computational Drug Repositioning
Efforts to maximize the indications potential and revenue from drugs that are already marketed are largely motivated by what Sir James Black, a Nobel Prize-winning pharmacologist advocated—“The most fruitful basis for the discovery of a new drug is to start with an old drug&r...
Saved in:
Main Authors: | Jaswanth K. Yella (Author), Suryanarayana Yaddanapudi (Author), Yunguan Wang (Author), Anil G. Jegga (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current trends and future prospects of drug repositioning in gastrointestinal oncology
by: Nayeralsadat Fatemi, et al.
Published: (2024) -
Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
by: Hanne-Line Rabben, et al.
Published: (2021) -
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease
by: Soo Youn Lee, et al.
Published: (2020) -
A computational multi-targeting approach for drug repositioning for psoriasis treatment
by: Akachukwu Ibezim, et al.
Published: (2021) -
Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
by: Xuan-Yi Ye, et al.
Published: (2017)